Telix Pharmaceuticals (TLX) Equity Ratio (2023 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Telix Pharmaceuticals (TLX) has disclosed Equity Ratio for 2 consecutive years, with 0.37 as the latest value for Q4 2024.

• Quarterly Equity Ratio rose 2.15% to 0.37 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 0.37 through Dec 2024, up 2.15% year-over-year, with the annual reading at 0.37 for FY2024, 2.15% up from the prior year.
• Equity Ratio for Q4 2024 was 0.37 at Telix Pharmaceuticals, up from 0.37 in the prior quarter.
• The five-year high for Equity Ratio was 0.37 in Q4 2024, with the low at 0.37 in Q4 2023.

Peer Comparison